PrimeRFP SCOUT · Federal Contract Profile

Amicus Therapeutics Us (KLJFGENKMD89)Federal contracts · 2 recompetes

Amicus Therapeutics Us holds $3.4M in federal volume across 74 award actions, with 100% at Department of Veterans Affairs (VA). SCOUT tracks 2 incumbent recompetes — an estimated $523K returning to market over the next 24 months (Moderate exposure). Primary work: Pharmaceutical Preparation (100% prime). Obligations are up 26% year over year.

$3.4M

Federal Volume

Recompetes (24mo)

Top Agency · 100% firm-wide

74

Award Actions

Small business

Set-Aside

Choose one — this changes what we ask next

Score my firm against Amicus Therapeutics Us

Email me when a Amicus Therapeutics Us recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS

Where they win

Sole agency

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$3.4M · 100% of firm total

Recompete exposure: Moderate · 2 in 24mo

Amicus Therapeutics Us has an estimated $523K in contracts returning to market over the next 24 months.

Part of the AMICUS THERAPEUTICS INC. corporate family · 3 entities

Metrics basis: local_db_api_validated

Who buys from them

Agency buyer map

1 buyers

Department of Veterans Affairs (VA)87 awards · repeat buyer · $3.4M

Recompete exposure & trajectory

Recompete exposure

Moderate

Amicus Therapeutics Us has an estimated $523K in contracts returning to market over the next 24 months. 1 within 6 months ($295K).

GALAFOLD 123 MG CAPSULE - NTE →

PIID: 36C25926F0001 · Expires 2026-11-14

$295K

GALAFOLD MEDICATION →

PIID: 36C24726F0100 · Expires 2027-02-22

$228K

Trajectory

▲ Expanding+26% YoYFY2025 vs FY2024

'23

'24

'25

“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”

— Shauna Weatherly, FedSubK

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Amicus Therapeutics Us hold?

Amicus Therapeutics Us (UEI KLJFGENKMD89) shows $3.4M across 74 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Amicus Therapeutics Us have?

Amicus Therapeutics Us shows $3.4M across 74 award actions. SCOUT tracks 2 incumbent recompetes ($523K) returning to market in the next 24 months.

Which agencies does Amicus Therapeutics Us work with?

Amicus Therapeutics Us’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (100%).

What is the UEI for Amicus Therapeutics Us?

The Unique Entity ID (UEI) for Amicus Therapeutics Us is KLJFGENKMD89.

Does Amicus Therapeutics Us have contracts coming up for recompete?

Yes — SCOUT tracks 2 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.